17 69

Cited 0 times in

The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy

 Seong Hyeon Kim  ;  Song Mi Lee  ;  Hei Cheul Jeung  ;  Ik Jae Lee  ;  Joon Seong Park  ;  Mina Song  ;  Dong Ki Lee  ;  Seung-Min Lee 
 NUTRIENTS, Vol.11(5) : 1145, 2019-05 
Journal Title
Issue Date
Aged ; Bile Duct Neoplasms / drug therapy ; Bile Duct Neoplasms / therapy* ; Body Composition ; Body Weight ; Diet ; Dietary Supplements* ; Energy Intake ; Female ; Humans ; Male ; Nutrition Therapy / methods* ; Nutritional Status ; Pancreatic Neoplasms / drug therapy ; Pancreatic Neoplasms / therapy* ; Prospective Studies ; Quality of Life ; Surveys and Questionnaires
pancreatic and bile duct cancer ; chemotherapy ; oral nutritional supplement (ONS) ; nutritional status ; patient-generated subjective global assessments ; Quality of Life Questionnaire Core 30
Chemotherapy may negatively affect nutritional status and quality of life (QOL) in pancreatic cancer patients. Our aim was to investigate the beneficial effects of oral nutrition supplements (ONS) on pancreatic and bile duct cancer patients undergoing chemotherapy. Among patients with progressive pancreatic and bile duct cancer receiving chemotherapy, the ONS group (n = 15) received two packs of ONS daily for 8 weeks while the non-ONS group (n = 19) did not. Anthropometric measures, dietary intake, nutritional status, and quality of life were assessed. ONS significantly increased daily intakes of energy, carbohydrates, proteins, and lipids at 8 weeks compared to the baseline. After 8 weeks, fat mass significantly increased in the ONS group. For patients in their first cycle of chemotherapy, body weight, fat-free mass, skeletal muscle mass, body cell mass, and fat mass increased in the ONS group but decreased in the non-ONS group. Fat mass increased in second or higher cycle only in the ONS group. Patient-generated subjective global assessments (PG-SGA) and fatigue scores in the Quality of Life Questionnaire Core 30 (QLQ-C30) improved in the ONS group. ONS might improve nutritional status by increasing fat mass and/or maintaining the body composition of pancreatic and bile duct cancer patients with chemotherapy, especially those in the first cycle, and alleviate fatigue symptoms.
Files in This Item:
T9992019206.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Park, Joon Seong(박준성) ORCID logo https://orcid.org/0000-0001-8048-9990
Lee, Dong Ki(이동기) ORCID logo https://orcid.org/0000-0002-0048-9112
Lee, Ik Jae(이익재) ORCID logo https://orcid.org/0000-0001-7165-3373
Jeung, Hei Cheul(정희철) ORCID logo https://orcid.org/0000-0003-0952-3679
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.